Impact of intravenous fluid therapy on variables of gut dysfunction
| Symptoms of GDF § | Interventional | Control | Odds Ratio [95% CI]* | P Trend | I2 (%)# |
|---|---|---|---|---|---|
| Nausea | 88/ 274 | 90/278 | 0.98 (0.67, 1.44) | 0.92 | 0 |
| Vomiting | 62/462 | 94/447 | 0.51 (0.28, 0.94) | 0.03 | 45 |
| Ileus | 66/832 | 80/828 | 0.83 (0.52, 1.32) | 0.42 | 23 |
| GI bleed | 15/592 | 10/587 | 1.48 (0.66, 3.35) | 0.34 | 0 |
| Anastomotic leak | 44/833 | 43/867 | 1.03 (0.54, 1.96) | 0.93 | 31 |
| Perforation | 7/238 | 6/234 | 1.05 (0.36, 3.09) | 0.92 | 0 |
| Intestinal obstruction | 5/451 | 11/445 | 0.53 (0.20, 1.45) | 0.22 | 0 |
Impact of enteral feeding on variables of gut dysfunction as classified by feeding categories
| Symptoms of GDF§ | Intervention Enteral | Control Parenteral | Odds [95% Ratio CI]* | P Trend | I2 [%]# |
|---|---|---|---|---|---|
| A. Route of feeding | |||||
| Vomiting | 605/2388 | 350/2598 | 2.02 (1.74, 2.35) | <0.01 | 0 |
| Diarrhoea | 190/1508 | 421/1515 | 1.75 (0.39, 7.86) | 0.46 | 92 |
| Abdominal distension | 123/1386 | 90/1390 | 1.51 (0.93, 2.45) | 0.10 | 28 |
| Ileus | 52/347 | 65/347 | 0.97 (0.34, 2.76) | 0.96 | 58 |
| Anastomotic leak | 28/540 | 54/545 | 0.54 (0.31, 0.95) | 0.03 | 14 |
| Intestinal ischaemia | 33/2493 | 16/2495 | 1.87 (0.72, 4.87) | 0.20 | 42 |
| Peritonitis | 5/265 | 18/268 | 0.31 (0.11, 0.87) | 0.03 | 0 |
| B. Timing of feeding | Early | Delayed | |||
| Vomiting | 3/56 | 19/54 | 0.11 (0.03, 0.41) | <0.01 | 0 |
| Diarrhoea | 27/39 | 23/40 | 2.45 (0.26, 22.75) | 0.43 | 69 |
| Abdominal Distension | 12/66 | 21/69 | 0.51 (0.22, 1.91) | 0.12 | 0 |
| C. Enteral feeding vs Nil-by-mouth (NBM) | Enteral | NBM | |||
| Vomiting | 21/220 | 22/219 | 0.72 (0.18, 2.90) | 0.65 | 0 |
| Abdominal Distension | 66/242 | 48/240 | 1.40 (0.75, 2.64) | 0.29 | 33 |
| GI bleed | 2/133 | 2/133 | 0.99 (0.17, 5.86) | 0.99 | 0 |
| Anastomotic leak | 12/244 | 24/236 | 0.46 (0.22, 0.95) | 0.04 | 0 |
Quality assessment for studies on the effect of enteral feeding on gut dysfunction (Cochrane quality grading for randomised controlled trials)7
Study Characteristics of 'good' quality studies on the impact of intravenous fluid therapy on gut dysfunction included in the systematic review
| Author | Year | Study Population | Study | Study | Study | Admission diagnosis | Experimental | Intravenous | Control | Intravenous | Dindo-Clavien |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Brandstrup9 | 2003 | elective colorectal resection | surgery | RCT | 141 | postsurgical | 69 | restricted | 72 | standard | |
| Holte10 | 2007 | elective surgery | surgery | RCT | 32 | elective colorectal surgery | 16 | restricted | 16 | liberal | |
| Holte11 | 2007 | post-surgery | surgery | RCT | 48 | knee arthroplasty | 24 | restricted | 24 | liberal | |
| Gonsalez-Fajardo12 | 2009 | post-surgery | surgery | RCT | 40 | vascular surgery transperitoneal aorto-iliac | 20 | restricted | 20 | standard | |
| Yates13 | 2013 | elective surgery | surgery | RCT | 206 | elective colorectal surgery | 104 | starch | 98 | crystalloid | |
| Ghodraty14 | 2017 | post-surgery | surgery | RCT | 91 | abdominal surgery | 46 | HES | 45 | ringers lactate | |
| Gómez-Izquierdo15 | 2017 | post-surgery | surgery | RCT | 128 | colorectal surgery | 4 | GDFT | 64 | control |
Study Characteristics of studies on the impact of enteral feeding on gut dysfunction included in the systematic review
| Author | Year | Study Population | Study Setting | Study type | Study patients | Admission diagnosis | Experimental | Control | Dindo-Clavien Classification# | Quality Grading* | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | ||||||||||
| Hoover55 | 1980 | surgical | surgical | RCT | 48 | surgical | 26 EF | 22IVF | Poor | ||||
| Adams56 | 1986 | ICU surgical | ICU | RCT | 46 | multiple trauma | 23 (EN) | 23(PN) | Poor | ||||
| Moore57 | 1986 | major abdo trauma | surgical | RCT | 59 | surgical | 29 (EN) | 30 (PN) | Poor | ||||
| Bower58 | 1986 | surgical | surgery | RCT | 20 | GI/pancreato-biliary surgery | 10 (EN-JeJ) | 10 (PN) | Poor | ||||
| Hamoui59 | 1989 | surgical | surgical | RCT | 19 | major GI surgery | 11EN | 8PN | Poor | ||||
| Von Meyenfeldt60 | 1992 | surgical | surgery | RCT | 101 | GI/colon cancer | 50 (EN) | 51(PN) | Poor | ||||
| Montecalvo61 | 1992 | surgical | surgical | RCT | 38 | surgical | 19 NG | 19 NJ | Poor | ||||
| Dunham62 | 1994 | critically ill | ICU | RCT | 37 | trauma | 12 (EN)+ 15 (PN) + 10(EN+PN) | Poor | |||||
| Borzotta63 | 1994 | trauma | surgical trauma | RCT | 48 | trauma | 27 (EN) | 21(PN) | Poor | ||||
| Daly64 | 1995 | surgical | surgical | RCT | 60 | surgical | 18ENSD; 12SD-IP; 19 ENSD-IP-OP; 11 EN-IP | Poor | |||||
| Carr65 | 1996 | post-surgical | surgery | RCT | 28 | intestinal resection | 14(EEN) | 14(CEN) | Poor | ||||
| Beier-Holgersen66 | 1996 | post-surgical | surgery | RCT | 60 | major abdominal surgery | 30(EEN) | 30 (placebo) | Poor | ||||
| Baigrie67 | 1996 | post-surgical | surgery | RCT | 97 | oesophagectomy/gastrectomy | 50 (EN) | 47(PN) | Poor | ||||
| VanBerge68 | 1997 | post-surgical | surgery | RCT | 57 | pancreatoduodenectomy | 30 (CON) | 27(CYC) | Poor | ||||
| Kalfarentzos69 | 1997 | critically ill | ICU | RCT | 38 | Severe acute pancreatitis | 18(EN) | 20 (PN) | |||||
| Heslin70 | 1997 | surgical | surgery | RCT | 195 | upper GI malignancy | 97 (EN) | 98(IVF) | Poor | ||||
| Reynolds71 | 1997 | major upper GI surgery | surgical | RCT | 67 | surgical | 33 (EN) | 34(PN) | Poor | ||||
| Stewart72 | 1998 | elective surgical | surgery | RCT | 80 | colorectal resections | 40 (EOF) | 40 (COF) | Poor | ||||
| Windsor73 | 1998 | surgical | surgical | RCT | 34 | acute pancreatitis | 16 EN | 18PN | Poor | ||||
| Singh74 | 1998 | surgical | surgical | RCT | 43 | surgical | 22JEJ | 21IVF | Poor | ||||
| Braga75 | 1998 | surgical | surgical | RCT | 166 | surgical | 55 STD-EN; 55 -STD-EN enriched; 56 TPN | Poor | |||||
| Taylor76 | 1999 | critically ill | ICU | RCT | 82 | head injury | 41TRO | 41 EN | Fair | ||||
| Pupelis77 | 2000 | critically ill | S-ICU | RCT | 60 | severe pancreatitis/peritonitis | 30 (JEN) | 30 (Control) | Poor | ||||
| Minard78 | 2000 | critically ill | ICU | RCT | 27 | head injury/trauma | 12(EEN) | 15(DEN) | Poor | ||||
| Powell79 | 2000 | critically ill | ICU | RCT | 27 | severe acute pancreatitis | 13 (EN) | 14(NBM) | Poor | ||||
| Kearns80 | 2000 | critically ill | ICU | RCT | 44 | critically ill | 23 G | 21 SI | Poor | ||||
| Bozzetti81 | 2001 | elective surgery | surgery | RCT | 317 | GIcancer | 159(EN) | 158(PN) | Poor | ||||
| Braga82 | 2001 | surgical | surgery | RCT | 257 | GIcancer | 126(EEN) | 131(PN) | Poor | ||||
| Montejo83 | 2002 | critically ill | ICU | RCT | 101 | critically ill | 50 (JEN) | 51(GEN) | Poor | ||||
| Davies84 | 2002 | critically ill | ICU | RCT | 73 | critically ill | 34 (NJ) | 39 (NG) | Poor | ||||
| Bertolini85 | 2003 | critically ill | ICU | RCT | 39 | Sepsis | 18(EN) | 17 (PN) | Poor | ||||
| Kompan86 | 2004 | critically ill | ICU | RCT | 52 | multiple trauma | 27(EEN) | 21(DEN) | Poor | ||||
| Malhotra87 | 2004 | post-surgical | surgery | RCT | 164 | perforated gut and peritonitis | 83 (EN) | 81(NBM) | Poor | ||||
| Kumar88 | 2006 | Surgical | surgical | RCT | 31 | surgical | 15 NG | 16 NJ | Poor | ||||
| Nguyen89 | 2007 | critically ill | ICU | RCT | 31 | critically ill | 23 (NJ) | 28 (NJ) | Poor | ||||
| Han-Guerts90 | 2007 | post-surgical | surgery | RCT | 150 | oesophagectomy | 71 (ND) | 79 (JEJ) | Poor | ||||
| Descahy91 | 2008 | critically ill | ICU | RCT | 100 | ICU | 50EEN | 50CEN | Poor | ||||
| Tien92 | 2009 | critically ill | ICU | RCT | 200 | ICU | 98TRO | 102 EN | Poor | ||||
| Barlow93 | 2011 | Surgical | surgery | RCT | 121 | upper GI malignancy | 64 (EN) | 57(NBM+IVF) | Poor | ||||
| Altintas94 | 2011 | critically ill | ICU | RCT | 71 | ICU | 30 (EN) | 41 (PN) | Poor | ||||
| Rice95 | 2011 | Surgical | surgical | RCT | 247 | surgical | EN 123 | 124 IVF | Poor | ||||
| Davies96 | 2013 | critically ill | ICU | RCT | 181 | ICU | 91 NJ | 89 NG | Poor | ||||
| Zhu97 | 2013 | post-surgical | surgery | RCT | 68 | pancreaticoduodenectomy | 34(JT) | 34(NJT) | Poor | ||||
| Sun98 | 2013 | critically ill | S-ICU | RCT | 60 | severe acute pancreatitis | 30(EEN) | 30(DEN) | Poor | ||||
| Kadamani99 | 2014 | critically ill | ICU | RCT# | 15 | critically ill | 15 (CON) | 15 (BOL) | Poor | ||||
| Boelens100 | 2014 | elective surgical | surgery | RCT | 123 | rectal surgery | 61(EEN) | 62(EPN) | Poor | ||||
| Harvey101 | 2014 | critically ill | ICU | RCT | 2388 | critically ill | 1197(EN) | 1191(PN) | Poor | ||||
| Ma102 | 2015 | acute surgical | surgery | RCT | 35 | acute pancreatitis | 17 (NTF) | 18(NPO) | Poor | ||||
| Bing Li103 | 2015 | post-surgical | surgery | RCT | 400 | gastrectomy | 200(EEN) | 200 (PN) | Poor | ||||
| Taylor104 | 2016 | critically ill | ICU | RCT | 50 | critically ill | 25 (NJ) | 25(NG + ProK) | Poor | ||||
| Ozen105 | 2016 | critically ill | ICU | RCT | 51 | critically ill | 26(no-GRV's) | 25(GRV's) | Poor | ||||
| Van Barneveld106 | 2016 | elective surgical | surgery | RCT | 123 | rectal ca malignancy | 61 (EEN) | 62(EPN) | Good | ||||
| Malik107 | 2016 | critically ill | ICU | RCT | 60 | critically ill | 30 (EF) | 30 (placebo) | Poor | ||||
| Fan108 | 2016 | critically ill | ICU | RCT | 80 | Severe TBI | 40 (EN) | 40 (PN) | Poor | ||||
| Stimac109 | 2016 | acute pancreatitis | pancreatitis | RCT | 214 | acute pancreatitis | 107 EN | 107 IVF | Poor | ||||
| Hongyin110 | 2017 | acute surgical | surgery | RCT | 161 | acute pancreatitis | 83 (APD)/61 EN) | 78(non-APD)/68(EN) | Poor | ||||
| Reigner111 | 2018 | critically ill | ICU | RCT | 2410 | shock | 1202(EN) | 1208(PN) | Fair | ||||
Study Characteristics of 'fair ' quality studies on the impact of intravenous fluid therapy on gut dysfunction_
| Author | Year | Study Population | Study | Study | Study | Admission | Experimental | Intravenous | Control | Intravenous | Dindo-Clavien |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gan16 | 2002 | major elective general, urologic, or gynaecologic surgery | surgery | RCT | 100 | postsurgical | 50 | GDFT | 50 | Standard | |
| Moretti1 7 | 2003 | Major elective cardiac surgery | surgery | RCT | 90 | postsurgical | 30 - HetaStarch normal saline; 30 Heta Starch Balanced | ||||
| Nisanevich18 | 2005 | elective intraabdominal surgery | surgery | RCT | 157 | postsurgical | 77 | Restrictive | 75 | Liberal | |
| Kabon19 | 2005 | open colonic resection | surgery | RCT | 253 | ICU surgical | 124 | Small volume | 129 | Large Volume | |
| Lopes20 | 2007 | High-risk surgery | surgery | RCT | 33 | ICU surgical | 17 | GDFT | 16 | Control | |
| Vermuelen21 | 2009 | elective major abdominal surgical procedures | surgical | RCT | 62 | surgical | 30 | Restricted | 32 | Standard | |
| Mayer22 | 2010 | major abdominal surgery | surgery | RCT | 60 | ICU surgical | 30 | GDFT | 30 | Standard | |
| SAFE 23 | 2011 | ICU | ICU | RCT | 1218 | ICU | 603 | Colloid | 615 | Crystalloid | |
| Guidet24 | 2012 | severe sepsis | ICU | RCT | 196 | ICU | 100 | Colloid | 96 | Crystalloid | |
| Perner25 | 2012 | severe sepsis | ICU | RCT | 798 | ICU | 398 | Colloid | 400 | Crystalloid | |
| Reddy26 | 2016 | critically ill | ICU | RCT | 69 | critically ill | 35 | plasmalyte | 34 | saline | |
Dindo-Clavien Classification
| Grade | Grade Definition |
|---|---|
| Grade I | Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside |
| Grade II | Requiring pharmacological treatment with drugs other than such allowed for grade I complications, Blood transfusions and total parenteral nutrition are also included |
| Grade III | Requiring surgical, endoscopic or radiological intervention Grade IIIa Intervention not under general anaesthesia Grade IIIb Intervention under general anaesthesia |
| Grade IV | Life-threatening complication (including CNS complications)* requiring IC/ICU management Grade IVa Single organ dysfunction (including dialysis) Grade IVb Multiorgan dysfunction) |
Study Characteristics of 'poor ' quality studies on the impact of intravenous fluid therapy on gut dysfunction_
| Author | Year | Study Population | Study | Study | Study | Admission diagnosis | Experimental | Intravenous | Control | Intravenous fluid | Dindo-Clavien | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prein27 | 1990 | post-surgery | surgery | RCT | 18 | modified Whipple's | 6- ringers' lactate; 6– starch; 6-albumin | I | II | III | IV | |||
| Salim28 | 1991 | elective surgery | surgery | RCT | 130 | Hartmann's procedure +/- cholecystectomy | 71 | early oral | 59 | conventional intravenous | ||||
| Yogendran29 | 1995 | elective surgery | surgical | RCT | 200 | surgical | 100 | Low-infusion | 100 | High infusion | ||||
| Wilkes30 | 2001 | elective, open surgical | surgical | RCT | 47 | surgical | 23 | Balanced | 24 | Saline | ||||
| Lobo 31 | 2002 | post-surgery | surgery | RCT | 20 | colorectal surgery | 10 | restricted | 10 | liberal | ||||
| Conway32 | 2002 | major bowel surgery | surgical | RCT | 57 | surgical | 28 | GDFT | 39 | Standard | ||||
| Venn33 | 2002 | hip fracture surgery | surgical | RCT | 90 | surgical | 29CON- VF ; CVP guided FT- 3 1 ; Doppler-guided FT- 30 | |||||||
| SAFE34 | 2004 | ICU | ICU | RCT | 6997 | ICU | 3497 | Colloid | 3500 | Crystalloid | ||||
| Parker35 | 2004 | hip fracture surgery | surgical | RCT | 396 | surgical | 198 | Colloid | 198 | Crystalloid | ||||
| Noblett36 | 2005 | elective colorectal resection | surgical | RCT | 108 | surgical | 54 | GDFT | 54 | Standard | ||||
| Wakeling37 | 2005 | large bowel surgery | surgical | RCT | 128 | surgical | 64 | GDFT | 64 | Standard | ||||
| Mackay38 | 2006 | elective colorectal surgery | surgical | RCT | 80 | surgical | 41 | Restricted | 39 | Standard | ||||
| En-quiang38 | 2009 | critically ill | S-ICU | RCT | 76 | severe acute pancreatitis | 30 | controlled fluid expansion | 30 | rapid fluid expansion | ||||
| Senagore40 | 2009 | laparoscopic | surgical | RCT | 64 | surgical | 21 GDFT/LR; 21 GDFT/HS;2 22 standard | |||||||
| Futier41 | 2010 | major abdominal surgery | surgery | RCT | 70 | postsurgical | 36 | Restricted-GDFT | 34 | Conservative GDFT | ||||
| Benes42 | 2010 | elective intraabdominal | surgery | RCT | 120 | ICU surgical | 60 | GDFT | 60 | Standard | ||||
| Pillai43 | 2011 | post-surgery | surgery | RCT | 66 | radical cystectomy | 34 | intervention | 32 | control | ||||
| Du44 | 2011 | critically ill | ICU | RCT | 41 | severe acute pancreatitis | 20 | starch | 21 | ringers' lactate | ||||
| James45 | 2011 | Blunt and penetrating | surgical | RCT | 109 | surgical | Penetrating trauma- HES 36 ; SAL 31 Blunt trauma- HES20 ; SAL 22 | |||||||
| Challand46 | 2012 | major elective colorectal | surgical | RCT | 179 | surgical | 90 | GDFT | 89 | Standard | ||||
| Myberg47 | 2012 | ICU | ICU | RCT | 7000 | ICU | 3500 | Colloid | 3500 | Crystalloid | ||||
| Srinivasa48 | 2012 | elective colectomy | surgical | RCT | 85 | surgical | 37 | GDFT Restricted | 37 | Restricted | ||||
| Zheng49 | 2013 | post-surgery | surgery | RCT | 60 | gastrointestinal surgery | 30 | GDFT | 30 | control | ||||
| Scheeren50 | 2013 | High-risk surgery | ICU | RCT | 52 | ICU | 26 | GDFT | 26 | Control | ||||
| Pestana51 | 2014 | post-surgery | S-ICU | RCT | 142 | abdominal surgery | 70 | GDFT | 72 | control | ||||
| Pearse52 | 2014 | Major Gastrointestinal | surgery | RCT | 734 | surgical | 368 | GDFT | 366 | Standard | ||||
| Peng53 | 2014 | elective surgery | surgery | RCT | 80 | orthopaedic surgery | 40 | GDFT | 40 | standard | ||||
| Reisinger54 | 2017 | elective colorectal resection | surgery | RCT | 58 | postsurgical | 27 | GDFT | 31 | Standard | ||||
Quality assessment for studies on the effect of intravenous fluid therapy on gut dysfunction (Cochrane quality grading for randomised controlled trials)7
Search Strategy
| # Searches Results |
|---|
| 1 Gastrointestinal Diseases/ |
| 2 ((gastrointestinal or intestin* or digestive) adj3 (dysfunction* or failure or disorder* or injur* or disease*)).mp. |
| 3 ((abdominal or gut or bowel or intestin*) adj3 (perforat* or infarct* or obstruct* or failure or ischemi*)).mp. |
| 4 gastroparesis.mp. or Gastroparesis/ |
| 5 gastrointestinal motilit*.mp. or exp Gastrointestinal Motility/ |
| 6 (dysmotilit* or intestinal motilit*).mp. 5645 |
| 7 Intra-Abdominal Hypertension/ |
| 8 (abdominal compartment syndrome* or intra abdominal hypertension or intraabdominal hypertension).mp. |
| 9 feed* intolerance.mp. |
| 10 ileus.mp. or Ileus/ |
| 11 Intestinal Obstruction/ or Intestinal Pseudo-Obstruction/ or pseudo obstruction.mp. or ogilvie’s syndrome.mp. |
| 12 (mesenteric or peritonitis).mp. 91360 |
| 13 or/1-12 282880 |
| 14 enteral nutrition/ or parenteral nutrition/ |
| 15 Parenteral Nutrition, Total/ |
| 16 ((enteral or parenteral) adj3 (feed* or nutrition)).mp. |
| 17 Fluid Therapy/ or intravenous fluid*.mp. |
| 18 (fluid* adj3 therap*).mp. |
| 19 (resuscitation adj3 fluid*).mp. |
| 20 vasoactive.mp. |
| 21 Vasoconstrictor Agents/ or vasoconstrictor*.mp. or vasopressor*.mp. |
| 22 inotrope*.mp. |
| 23 or/14-22 |
| 24 intensive care/ or critical illness/ |
| 25 Intensive Care Units/ |
| 26 General Surgery/ |
| 27 Postoperative Complications/ or Postoperative Care/ |
| 28 (intensive care or ICU or critical care or critical* ill*).mp. |
| 29 (surgery or surgical or postoperative).mp. |
| 30 or/24-29 |
| 31 randomized controlled trial.pt. |
| 32 controlled clinical trial.pt. |
| 33 randomized.ab. |
| 34 placebo.ab. 35 drug therapy.fs. |
| 36 randomly.ab. |
| 37 trial.ab. 38 groups.ab. |
| 39 or/31-38 |
| 40 adult/ or aged/ or “aged, 80 and over”/ or frail elderly/ or middle aged/ or (adult* or middle aged or older or old or aged or |
| elderly or geriatric* or frail).mp. |
| 41 13 and 23 and 30 and 39 and 40 |
| 42 exp animals/ not humans.sh |
| 43 41 not 42 |